Alzamend Neuro, Inc. (ALZN) has 6 SEC Form 4 insider filings on record in the last 90 days. That includes 2 insider purchases totalling $222K, and 1 sales totalling $3K. Most recent filing: Aug. 31, 2026.
| Date | Insider | Value | Shares | Stake | Pre-planned | Links |
|---|---|---|---|---|---|---|
| Aug. 31, 2026 filed April 14, 2026 | AULT MILTON C III Director | +$110,965 | 110,388 | — | No | |
|
|
||||||
| Aug. 31, 2026 filed April 14, 2026 | AULT MILTON C III Director | +$110,965 | 110,388 | — | No | |
|
|
||||||
| Aug. 31, 2026 filed Aug. 26, 2026 | AULT MILTON C III Director | −$3,116 | 2,000 | −100% | No | |
|
|
||||||
| Aug. 20, 2026 filed July 31, 2026 | Hyperscale Data, Inc. Director | $7,500,000 | 7,500 | 0% | No | |
|
|
||||||
| Aug. 4, 2026 filed July 31, 2026 | Hyperscale Data, Inc. Director | $7,500,000 | 7,500 | 0% | No | |
|
|
||||||
Showing the 5 most recent of 6 filings in the last 90 days.
Form 4 is the filing company officers, directors and 10% shareholders must submit to the SEC within two business days of trading their own company's stock. Open-market purchases generally carry more signal than sales, which are often scheduled in advance. More on how this works.
Real-time Telegram alerts the moment a Form 4 is filed. Filings shown here are delayed by 72 hours.
Start free